![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/68 | (2017.01) |
A61K 38/19 | (2006.01) | ||
C07K 16/24 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 19/02 | (2006.01) |
(11) | Number of the document | 3658192 |
(13) | Kind of document | T |
(96) | European patent application number | 18833113.6 |
Date of filing the European patent application | 2018-11-29 | |
(97) | Date of publication of the European application | 2020-06-03 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
(46) | Date of publication of the claims translation | 2021-07-12 |
(86) | Number | PCT/IB2018/059482 |
Date | 2018-11-29 |
(87) | Number | WO 2019/106609 |
Date | 2019-06-06 |
(30) | Number | Date | Country code |
201762593776 P | 2017-12-01 | US | |
201762595054 P | 2017-12-05 | US |
(72) |
HOBSON, Adrian D., US
MCPHERSON, Michael J., US
WAEGELL, Wendy, US
GOESS, Christian, US
HERNANDEZ, Axel, Jr., US
WANG, Lu, US
WANG, Lu, US
MARVIN, Christopher C., US
SANTORA, Ling C., US
|
(73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Gliukokortikoidų receptorių agonistas ir jo imunokonjugatai |
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF |
Payment date | Validity (years) | Amount | |
2024-10-11 | 7 | 162.00 EUR |
2025-11-29 |